KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares IssuedShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Shares Issued (2016 - 2025)

Boston Scientific (BSX) has disclosed Shares Issued for 17 consecutive years, with $20.0 million as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 28.57% to $20.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $282.0 million through Dec 2025, up 22.61% year-over-year, with the annual reading at $282.0 million for FY2025, 22.61% up from the prior year.
  • Shares Issued hit $20.0 million in Q4 2025 for Boston Scientific, down from $115.0 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $115.0 million in Q1 2025 to a low of $6.0 million in Q2 2022.
  • Historically, Shares Issued has averaged $47.0 million across 5 years, with a median of $30.0 million in 2024.
  • Biggest five-year swings in Shares Issued: tumbled 93.1% in 2021 and later skyrocketed 350.0% in 2023.
  • Year by year, Shares Issued stood at $8.0 million in 2021, then skyrocketed by 137.5% to $19.0 million in 2022, then fell by 10.53% to $17.0 million in 2023, then surged by 64.71% to $28.0 million in 2024, then dropped by 28.57% to $20.0 million in 2025.
  • Business Quant data shows Shares Issued for BSX at $20.0 million in Q4 2025, $115.0 million in Q3 2025, and $32.0 million in Q2 2025.